Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
STR Biotech is a South Korean biotechnology company founded in 2000 that specializes in the research, development, and production of functional food ingredients and natural health products. The company leverages its proprietary bio-conversion and fermentation platforms to enhance the bioavailability and efficacy of natural extracts. Their core product line includes clinically validated ingredients for immune support, liver protection, and fatigue recovery, which are supplied to global nutraceutical and pharmaceutical partners. STR Biotech is recognized for its expertise in obtaining "Individually Recognized Ingredient" status from the Korean Ministry of Food and Drug Safety. The company maintains a strong focus on R&D, collaborating with academic institutions to explore new therapeutic applications for traditional natural resources. STR Biotech is currently listed on the KONEX exchange and operates manufacturing facilities that comply with Good Manufacturing Practice standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on STR Biotech.